BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/25/2016 7:30:00 PM | Browse: 1139 | Download: 1492
 |
Received |
|
2015-07-09 08:38 |
 |
Peer-Review Started |
|
2015-07-14 10:31 |
 |
To Make the First Decision |
|
2015-10-08 16:07 |
 |
Return for Revision |
|
2015-10-13 14:25 |
 |
Revised |
|
2015-10-16 05:23 |
 |
Second Decision |
|
2015-11-27 15:57 |
 |
Accepted by Journal Editor-in-Chief |
|
2015-11-29 12:55 |
 |
Accepted by Executive Editor-in-Chief |
|
2015-12-08 15:18 |
 |
Articles in Press |
|
2015-12-08 15:18 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-02-19 11:45 |
 |
Publish the Manuscript Online |
|
2016-02-25 19:30 |
ISSN |
1949-8454 (online) |
Open Access |
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Minireviews |
Article Title |
API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis
|
Manuscript Source |
Invited Manuscript |
All Author List |
Shaun Rosebeck, Megan S Lim, Kojo SJ Elenitoba-Johnson, Linda M McAllister-Lucas and Peter C Lucas |
Funding Agency and Grant Number |
|
Corresponding Author |
Peter C Lucas, MD, PhD, Department of Pathology and Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, United States. lucaspc@upmc.edu |
Key Words |
Oncogene; Fusion oncoprotein; Lymphoma; Chromosomal translocation; Ubiquitination; Apoptosis; Nuclear factor-κB; Caspases |
Core Tip |
We summarize the identification of novel API2-mucosa-associated lymphoid tissue (MALT) 1-interacting proteins that uniquely mediate the cellular effects of the fusion oncoprotein but not wild-type API2 or MALT1. API2-MALT1 recruits receptor interacting protein 1 and tumor necrosis factor (TNF) receptor associated factor 2, which normally function downstream of the TNF receptor, and utilizes these proteins to communicate unregulated canonical nuclear factor-κB (NF-κB) in a manner that does not depend on the protease activity of MALT1. Simultaneously, NF-κB inducing kinase is recruited to API2-MALT1 and is proteolytically cleaved by the MALT1 protease domain to generate a stable, non-canonical NF-κB-activating fragment. Finally, LIM domain and actin-binding protein 1 is similarly recruited and cleaved as an API2-MALT1 specific target and its cleavage media-tes an NF-κB-independent mechanism of oncogenesis. Additional factors, including SMAC and BCL10, may also play key roles as API2-MALT1 binding partners and downstream signaling factors. Thus, the API2-MALT1 fusion utilizes a distinct set of protein-protein interactions to leverage multiple, divergent mechanisms and achieve potent oncogenic reprogramming of affected B cells.
|
Publish Date |
2016-02-25 19:30 |
Citation |
Rosebeck S, Lim MS, Elenitoba-Johnson KSJ, McAllister-Lucas LM, Lucas PC. API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis. World J Biol Chem 2016; 7(1): 128-137 |
URL |
http://www.wjgnet.com/1949-8454/full/v7/i1/128.htm |
DOI |
http://dx.doi.org/10.4331/wjbc.v7.i1.128 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345